SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000921895-09-000469
Filing Date
2009-02-17
Accepted
2009-02-17 15:08:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga206588tra_12312008.htm SC 13G/A 235337
  Complete submission text file 0000921895-09-000469.txt   237484
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 09611404
SIC: 2834 Pharmaceutical Preparations

Mailing Address 399 PARK AVENUE 38TH FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE 38TH FLOOR NEW YORK NY 10022 2127058700
ACCIPITER CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001280190 (see all company filings)

IRS No.: 134220800 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A